Ology Bioservices Wins $106M Army Contract for COVID-19 Vaccine Manufacturing Support

Ology Bioservices has won a one-year, $106.3M reserve production capacity contract for more than 186M doses of COVID-19 vaccines and other treatments to support the Trump administration's Operation Warp Speed.

Army Contracting Command received eight bids for the firm-fixed-price contract that seeks to address an urgent domestic requirement for aseptic fill and finish services amid the coronavirus pandemic, the Department of Defense said Tuesday.

The Alachua, Fla.-based biopharmaceutical company received $53.1M at the time of award and is expected to complete work by Aug. 10, 2021.

Video of the Day

GovCon Wire Logo

Sign Up Now! GovCon Wire provides you with Daily Updates and News Briefings about Contract Awards

Related Articles